MedPath

Predictive Factors for Failure or Success of Endoscopic Treatment of Superficial Colorectal Tumors

Completed
Conditions
Superficial Colorectal Tumors
Interventions
Other: Evaluation of the long-term complete remission rate (> 12 months)
Registration Number
NCT03470883
Lead Sponsor
Institut Paoli-Calmettes
Brief Summary

To evaluate the long-term complete remission rate (\> 12 months) after endoscopic treatment of early neoplastic colorectal lesions.

Detailed Description

Intra-mucous colorectal neoplasia lesions (or even with minimal mucosal infiltration), formerly treated surgically, are increasingly treated endoscopically.

The IPC as a center for interventional endoscopy has been taking care of these lesions for several years.

Resection techniques have diversified since the 2000s (polypectomy, monobloc or piecemeal mucosectomy, submucosal dissection ... etc) and the endoscopy team has developed its various techniques within the institute ; Practice has evolved and has not been studied or evaluated in recent years. The purpose of this study is to evaluate practices and to compare results with the literature, and to identify predictive factors for the failure or success of endoscopic treatment of these early neoplastic lesions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patient having undergone endoscopic resection of a colorectal lesion stage 4 or 5 of the modified Vienna classification during the last 5 years at the institute.
Exclusion Criteria
  • Adenomas with low grade dysplasia
  • Endoscopic control not available

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
endoscopic resection of a colorectal lesionEvaluation of the long-term complete remission rate (> 12 months)Patient having undergone endoscopic resection of a colorectal lesion stage 4 or 5 of the modified Vienna classification during the last 5 years at the institute.
Primary Outcome Measures
NameTimeMethod
Complete long-term remission (> 12 months)13 months

Evaluation of the long-term complete remission rate (\> 12 months)

Secondary Outcome Measures
NameTimeMethod
Rates of medium and long-term recurrence13 months

Recurrence rate in the medium and long term

Endoscopic description and anatomopathological results1 day

Endoscopic and / or anatomopathological predictive factors of success (complete long-term remission)

Absence of residual lesion on early control (3 to 6 months)3 to 6 months

Medium-term response rate (3 to 6 months)

Management of medium and long-term recurrence13 months

Management of recurrence (endoscopic revision or surgery)

Morbidity and mortality rates13 months

Morbidity and mortality rate of endoscopic resection

Lymph node or visceral metastatic evolution rate13 months

Rate of pejorative lymph node or metastatic evolution (especially for lesions with microinfiltration of the submucosa)

Trial Locations

Locations (1)

Institut Paoli Calmettes

🇫🇷

Marseille, Bouches Du Rhone, France

© Copyright 2025. All Rights Reserved by MedPath